"Subrenal Capsule Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
In vivo method of screening investigative anticancer drugs and biologic response modifiers for individual cancer patients. Fresh tumor tissue is implanted under the kidney capsule of immunocompetent mice or rats; gross and histological assessments follow several days after tumor treatment in situ.
Descriptor ID |
D013370
|
MeSH Number(s) |
E05.337.550.200.900.830 E05.624.850.830
|
Concept/Terms |
Subrenal Capsule Assay- Subrenal Capsule Assay
- Assay, Subrenal Capsule
- Assays, Subrenal Capsule
- Subrenal Capsule Assays
- Subrenal Capsule Xenograft Assay
|
Below are MeSH descriptors whose meaning is more general than "Subrenal Capsule Assay".
Below are MeSH descriptors whose meaning is more specific than "Subrenal Capsule Assay".
This graph shows the total number of publications written about "Subrenal Capsule Assay" by people in this website by year, and whether "Subrenal Capsule Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Subrenal Capsule Assay" by people in Profiles.
-
Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Cancer Res. 1998 Jun 15; 58(12):2568-75.
-
The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. J Urol. 1991 Nov; 146(5):1418-24.
-
Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model. Urol Res. 1990; 18(4):245-50.